NEW YORK (GenomeWeb News) – Fred Hutchinson Cancer Research Center scientists will use a $13 million award from the National Cancer Institute to fund a consortium that will use genome sequencing and genome-wide association study data to identify rare genetic variants that may be involved in colorectal cancer.

Ulrike Peters, a member of the Hutchinson Center's Public Health Sciences Division, will lead the effort, which also will involve partners through the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), for which Peters is principal investigator.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.